ipilimumab
bms
['melanoma', 'yervoy']
til therapy bests yervoy in head-to-head melanoma trial; will it reach patients without pharma? based on data from a randomized trial presented at esmo, the netherlands cancer institute is exploring the possibility of seeking regulatory approval for... 